We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Groundbreaking Procedure Combines New Treatments for Liver Tumors

By HospiMedica International staff writers
Posted on 08 Dec 2025

Removing or destroying liver tumors often requires patients to undergo two separate procedures, exposing them to multiple hospital stays, repeated anesthesia, and longer recovery times. More...

Traditional approaches also rely on less precise techniques when CT imaging is not available in the operating room, limiting accuracy when tumors are hard to reach. Now, a new approach combines robotic liver resection and CT-guided ablation in a single operation to reduce patient burden and improve precision.

This combined procedure was developed and performed at Amsterdam UMC (Amsterdam, Netherlands), where teams integrated robotic surgery with CT-guided interventional oncology workflows inside a hybrid operating room. The method brings together two standard liver tumor treatments—robot-assisted resection and image-guided ablation—within one tightly coordinated surgical session. CT guidance allows real-time visualization of tumor targets during ablation, while robotic instruments support highly controlled liver resection.

During the procedure, surgeons removed tumor tissue robotically and then used CT imaging to guide heat-based ablation of additional lesions, ensuring complete coverage while preserving healthy liver tissue. This dual-modality approach reduces the need for large incisions and avoids staging the treatments separately. Initial use of the technique followed months of preparation, ensuring safe integration of surgical and interventional teams.

A clinical study is now underway at Amsterdam UMC to evaluate safety, feasibility, and early outcomes in 15 patients with liver tumors. The goal is to compare the single-session method with standard, separate procedures to determine its benefits in recovery time, complication rates, and overall effectiveness. Depending on the results, a larger multicenter trial involving additional UMCs is planned.

Performing both treatments at once can significantly reduce strain on patients by avoiding repeat anesthesia and hospital admissions, while advanced ablation technologies can improve precision. The researchers expect this new treatment will become accessible to all patients with liver tumors within three years.

"Until now, these procedures could only be done separately or with less precise techniques through a large incision in the abdomen or traditional laparoscopic surgery without a CT scanner,” said Rutger-Jan Swijnenburg, MD, liver surgeon at Amsterdam UMC and co-developer of the combined procedure. “The patient had to undergo two separate hospital stays and receive anesthesia twice. By performing both procedures within one operation, we minimize the burden on the patient."

Related Links:
Amsterdam UMC


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.